9-129719288-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_016307.4(PRRX2):c.317G>A(p.Arg106Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000343 in 1,458,134 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016307.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRRX2 | NM_016307.4 | c.317G>A | p.Arg106Gln | missense_variant | 2/4 | ENST00000372469.6 | NP_057391.1 | |
PRRX2 | XM_017014803.1 | c.137G>A | p.Arg46Gln | missense_variant | 2/4 | XP_016870292.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRRX2 | ENST00000372469.6 | c.317G>A | p.Arg106Gln | missense_variant | 2/4 | 1 | NM_016307.4 | ENSP00000361547.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000413 AC: 1AN: 242340Hom.: 0 AF XY: 0.00000757 AC XY: 1AN XY: 132110
GnomAD4 exome AF: 0.00000343 AC: 5AN: 1458134Hom.: 0 Cov.: 31 AF XY: 0.00000414 AC XY: 3AN XY: 725122
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2023 | The c.317G>A (p.R106Q) alteration is located in exon 2 (coding exon 2) of the PRRX2 gene. This alteration results from a G to A substitution at nucleotide position 317, causing the arginine (R) at amino acid position 106 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at